ArticleJournal of the American Society of Nephrology : JASN2025

Authors' Reply: Effects of Zibotentan and Dapagliflozin on Fluid Retention in Patients with CKD: Need More Evidence.

Hiddo J L Heerspink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.